Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment

JHEP Reports - Tập 3 - Trang 100176 - 2021
Giacomo Zaccherini1,2, Emmanuel Weiss2,3,4, Richard Moreau2,4,5
1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
2European Foundation for the Study of Chronic Liver Failure (EF-CLIF), Barcelona, Spain
3Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP.Nord, Paris, France
4Inserm et Université de Paris, Centre de Recherche sur l'Inflammation (CRI), Paris, France
5Service d'Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France

Tài liệu tham khảo

Arroyo, 2020, Acute-on-chronic liver failure, N Engl J Med, 382, 2137, 10.1056/NEJMra1914900 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Bajaj, 2014, Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures, Hepatology, 60, 250, 10.1002/hep.27077 Wu, 2018, Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure, Gut, 67, 2181, 10.1136/gutjnl-2017-314641 Sarin, 2019, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update, Hepatol Int, 13, 353, 10.1007/s12072-019-09946-3 Sarin, 2009, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL), Hepatol Int, 3, 269, 10.1007/s12072-008-9106-x Sarin, 2014, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014, Hepatol Int, 8, 453, 10.1007/s12072-014-9580-2 Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 1038, 10.1016/j.jhep.2014.06.012 O'Leary, 2018, NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis, Hepatology, 67, 2367, 10.1002/hep.29773 Fernández, 2018, Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis, Gut, 67, 1870, 10.1136/gutjnl-2017-314240 Mahmud, 2019, Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis, Hepatology, 69, 2150, 10.1002/hep.30494 Piano, 2017, Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis, J Hepatol, 67, 1177, 10.1016/j.jhep.2017.07.008 Sundaram, 2018, Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis, J Hepatol, 69, 617, 10.1016/j.jhep.2018.04.016 Gustot, 2015, Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, 62, 243, 10.1002/hep.27849 Li, 2016, Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B, Sci Rep, 6, 25487, 10.1038/srep25487 Kim, 2016, Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition, PLoS One, 11, e0146745, 10.1371/journal.pone.0146745 Hernaez, 2019, Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA, J Hepatol, 70, 639, 10.1016/j.jhep.2018.12.018 Amarapurkar, 2015, Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality, Indian J Gastroenterol, 34, 216, 10.1007/s12664-015-0574-3 Shi, 2015, Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults, Hepatology, 62, 232, 10.1002/hep.27795 Abbas, 2015, Pattern and profile of chronic liver disease in acute on chronic liver failure, Hepatol Int, 9, 366, 10.1007/s12072-015-9627-z Chen, 2019, Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region, Hepatol Int, 13, 695, 10.1007/s12072-019-09992-x Karvellas, 2018, Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis, Crit Care Med, 46, 1783, 10.1097/CCM.0000000000003369 Clària, 2016, Systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740 Iwasaki, 2015, Control of adaptive immunity by the innate immune system, Nat Immunol, 16, 343, 10.1038/ni.3123 Bianchi, 2007, DAMPs, PAMPs and alarmins: all we need to know about danger, J Leukoc Biol, 81, 1, 10.1189/jlb.0306164 Bernardi, 2015, Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis, J Hepatol, 63, 1272, 10.1016/j.jhep.2015.07.004 Moreau, 2018, Effects of long-term norfloxacin therapy in patients with advanced cirrhosis, Gastroenterology, 155, 1816, 10.1053/j.gastro.2018.08.026 Wiest, 2014, Pathological bacterial translocation in liver cirrhosis, J Hepatol, 60, 197, 10.1016/j.jhep.2013.07.044 Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201 Petrasek, 2013, STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease, Proc Natl Acad Sci USA, 110, 16544, 10.1073/pnas.1308331110 Evankovich, 2010, High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity, J Biol Chem, 285, 39888, 10.1074/jbc.M110.128348 Li, 2015, Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation, J Hepatol, 63, 50, 10.1016/j.jhep.2015.01.029 Bortoluzzi, 2013, Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms, Hepatology, 57, 266, 10.1002/hep.26021 Rodríguez-Roisin, 2008, Hepatopulmonary syndrome - a liver-induced lung vascular disorder, N Engl J Med, 358, 2378, 10.1056/NEJMra0707185 Gustot, 2009, Severe sepsis in cirrhosis, Hepatology, 50, 2022, 10.1002/hep.23264 Alobaidi, 2015, Sepsis-associated acute kidney injury, Semin Nephrol, 35, 2, 10.1016/j.semnephrol.2015.01.002 Moreau, 2020, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, J Hepatol, 72, 688, 10.1016/j.jhep.2019.11.009 Bajaj, 2018, Prediction of fungal infection development and their impact on survival using the NACSELD cohort, Am J Gastroenterol, 113, 556, 10.1038/ajg.2017.471 Li, 2020, Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure, World J Clin Cases, 8, 1042, 10.12998/wjcc.v8.i6.1042 Su, 2020, Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure, Eur J Gastroenterol Hepatol, 10.1097/MEG.0000000000001699 Cai, 2017, Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure, Medicine (Baltimore), 96, e8057, 10.1097/MD.0000000000008057 Clària, 2019, Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis, Hepatology, 69, 1686, 10.1002/hep.30363 Bernsmeier, 2015, Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK, Gastroenterology, 148, 603, 10.1053/j.gastro.2014.11.045 Bernsmeier, 2018, CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure, Gut, 67, 1155, 10.1136/gutjnl-2017-314184 Weichselbaum, 2020, Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis, J Hepatol, 73, 303, 10.1016/j.jhep.2020.02.017 Rolas, 2018, NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation, Gut, 67, 1505, 10.1136/gutjnl-2016-313443 McPhail, 2018, Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units, Crit Care Med, 46, 705, 10.1097/CCM.0000000000002961 Galbois, 2014, Improved prognosis of septic shock in patients with cirrhosis: a multicenter study, Crit Care Med, 42, 1666, 10.1097/CCM.0000000000000321 Karvellas, 2014, Advances in management and prognostication in critically ill cirrhotic patients, Curr Opin Crit Care, 20, 210, 10.1097/MCC.0000000000000067 Weil, 2017, Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis, Ann Intensive Care, 7, 33, 10.1186/s13613-017-0249-6 Piano, 2019, Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide, Gastroenterology, 156, 1368, 10.1053/j.gastro.2018.12.005 2018, EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 Gustot, 2019, Acute-on-chronic liver failure in patients with alcohol-related liver disease, J Hepatol, 70, 319, 10.1016/j.jhep.2018.12.008 Sersté, 2018, The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis, J Hepatol, 69, 318, 10.1016/j.jhep.2018.02.022 Forrest, 2018, Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis, J Hepatol, 69, 1200, 10.1016/j.jhep.2018.06.019 Trebicka, 2020, Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS, J Hepatol, 73, 1082, 10.1016/j.jhep.2020.04.024 Bernardi, 2020, Albumin in decompensated cirrhosis: new concepts and perspectives, Gut, 69, 1127, 10.1136/gutjnl-2019-318843 Fernández, 2019, Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis, Gastroenterology, 157, 149, 10.1053/j.gastro.2019.03.021 Arroyo, 2014, Human serum albumin, systemic inflammation, and cirrhosis, J Hepatol, 61, 396, 10.1016/j.jhep.2014.04.012 O'Brien, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2, Nat Med, 20, 518, 10.1038/nm.3516 Paugam-Burtz, 2020, Management of liver failure in general intensive care unit, Anaesth Crit Care Pain Med, 39, 143, 10.1016/j.accpm.2019.06.014 Fernández, 2020, Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis, Clin Gastroenterol Hepatol, 18, 963, 10.1016/j.cgh.2019.07.055 Gaudry, 2020, Delayed vs. early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials, Lancet, 395, 1506, 10.1016/S0140-6736(20)30531-6 Zhang, 2015, Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin, J Crit Care, 30, 969, 10.1016/j.jcrc.2015.05.006 Karvellas, 2019, Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION), Can J Anaesth, 66, 1151, 10.1007/s12630-019-01454-0 Bañares, 2013, Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial, Hepatology, 57, 1153, 10.1002/hep.26185 Kribben, 2012, Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure, Gastroenterology, 142, 782, 10.1053/j.gastro.2011.12.056 Gerth, 2017, Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure - a retrospective analysis, Crit Care Med, 45, 1616, 10.1097/CCM.0000000000002562 Shen, 2016, Survival benefits with artificial liver support system for acute-on-chronic liver failure: a time series-based meta-analysis, Medicine (Baltimore), 95, e2506, 10.1097/MD.0000000000002506 Smets, 2019, Transplantation, 103, 1903, 10.1097/TP.0000000000002605 Sundaram, 2019, Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation, Gastroenterology, 156, 1381, 10.1053/j.gastro.2018.12.007 Levesque, 2017, Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation, Liver Int, 37, 684, 10.1111/liv.13355 Artru, 2017, Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3, J Hepatol, 67, 708, 10.1016/j.jhep.2017.06.009 Arroyo, 2019, Acute-on-chronic liver failure in cirrhosis requires expedited decisions for liver transplantation, Gastroenterology, 156, 1248, 10.1053/j.gastro.2019.03.004 Hernaez, 2020, Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure, J Hepatol Sundaram, 2019, Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients, Hepatology, 70, 334, 10.1002/hep.30624 Weiss, 2020, When is a critically ill cirrhotic patient too sick to transplant? Development of consensus criteria by a multidisciplinary panel of 35 international experts, Transplantation, 10.1097/TP.0000000000003364 Artzner, 2020, Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors, Am J Transplant, 20, 2437, 10.1111/ajt.15852